Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI.

about

Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI.

Item

http://www.wikidata.org/entity/Q55255348

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Grading of pancreatic neuroend ...... dynamic contrast-enhanced MRI.

@en

Grading of pancreatic neuroend ...... dynamic contrast-enhanced MRI.

@nl

type

Item

label

Grading of pancreatic neuroend ...... dynamic contrast-enhanced MRI.

@en

Grading of pancreatic neuroend ...... dynamic contrast-enhanced MRI.

@nl

prefLabel

Grading of pancreatic neuroend ...... dynamic contrast-enhanced MRI.

@en

Grading of pancreatic neuroend ...... dynamic contrast-enhanced MRI.

@nl

P1476

Grading of pancreatic neuroend ...... dynamic contrast-enhanced MRI.

@en

P2093

Didi Wen

http://www.w3.org/2001/XMLSchema#string

Guangwen Zhang

http://www.w3.org/2001/XMLSchema#string

Hong Yin

http://www.w3.org/2001/XMLSchema#string

Jing Ren

http://www.w3.org/2001/XMLSchema#string

Weiwei Zhao

http://www.w3.org/2001/XMLSchema#string

Xufang Huang

http://www.w3.org/2001/XMLSchema#string

Yi Huan

http://www.w3.org/2001/XMLSchema#string

Zhiyong Quan

http://www.w3.org/2001/XMLSchema#string

Zhongqiang Shi

http://www.w3.org/2001/XMLSchema#string

P2860

New strategies for advanced neuroendocrine tumors in the era of targeted therapy

Gastroenteropancreatic high-grade neuroendocrine carcinoma

Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology

Imaging hemodynamics.

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Imaging of tumor angiogenesis: functional or targeted?

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum.

Consensus guidelines for the management and treatment of neuroendocrine tumors.

P304

8349-8356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8384

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29805568

http://www.w3.org/2001/XMLSchema#string

P932

5950181

http://www.w3.org/2001/XMLSchema#string